Provided by Tiger Trade Technology Pte. Ltd.

CALCIMEDICA

0.5728
-0.0104-1.78%
Post-market: 0.58140.0086+1.50%18:48 EDT
Volume:271.59K
Turnover:157.06K
Market Cap:19.56M
PE:-0.43
High:0.6000
Open:0.5930
Low:0.5608
Close:0.5832
52wk High:7.20
52wk Low:0.4606
Shares:34.14M
Float Shares:19.81M
Volume Ratio:0.75
T/O Rate:1.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3306
EPS(LYR):-1.9700
ROE:-365.70%
ROA:-63.58%
PB:3.55
PE(LYR):-0.29

Loading ...

Calcimedica Files Initial Beneficial Ownership Statement for Alafi Capital Co LLC

Reuters
·
Jul 11

Calcimedica Files Form 3 Initial Beneficial Ownership Statement for Director Evgeny Zaytsev

Reuters
·
Jul 08

CalciMedica Announces Board Expansion and Leadership Transition

TIPRANKS
·
Jul 08

Calcimedica Names Evgeny Zaytsev to Board as Director Expands to Eight Members

Reuters
·
Jul 08

Calcimedica Director Fred A. Middleton Acquires 248,972 Common Shares Worth $200,000

Reuters
·
Jun 29

CalciMedica Advances Auxora After Favorable FDA Safety Review

TIPRANKS
·
Jun 25

Analysts Offer Insights on Healthcare Companies: OnKure Therapeutics (OKUR) and CalciMedica (CALC)

TIPRANKS
·
Jun 25

CalciMedica Says Auxora Phase 2 Trial May Continue Dosing After FDA Review

MT Newswires Live
·
Jun 24

CalciMedica Amends Loan, Issues New Equity Warrants

TIPRANKS
·
Jun 24

CalciMedica announces $49M private placement

TIPRANKS
·
Jun 24

Calcimedica - Proceeds to Support Phase 1B Auxora Study in Pah and Cm5480 Ind Clearance, Data Expected Mid-2027

THOMSON REUTERS
·
Jun 24

Calcimedica - Anticipates Cash Runway into Second Half of 2027 with Upfront Proceeds

THOMSON REUTERS
·
Jun 24

Calcimedica Announces Private Placement Financing for up to Approximately $49 Million to Advance Pulmonary Hypertension Program

THOMSON REUTERS
·
Jun 24

Calcimedica - FDA Review Allows Calcimedica to Continue Dosing Auxora in Kourage Trial

THOMSON REUTERS
·
Jun 24

Calcimedica Announces Clinical Development of Auxora May Proceed Following FDA Review of Kourage Trial Interim Safety Data

THOMSON REUTERS
·
Jun 24

Calcimedica - Expects FDA Feedback on Auxora Pancreatitis Program in Q3 2026

THOMSON REUTERS
·
Jun 24

Calcimedica - Lender Extends Interest-only Period to Sept 30, 2027 and Maturity to Sept 1, 2029 - SEC Filing

THOMSON REUTERS
·
Jun 24

Calcimedica - Enters First Amendment to Loan and Security Agreement on June 23, 2026 - SEC Filing

THOMSON REUTERS
·
Jun 24

Calcimedica Issues Unregistered Warrant to Buy 1,000,000 Shares at USD 1 Each

Reuters
·
Jun 24

Analysts Are Bullish on These Healthcare Stocks: Meiragtx Holdings (MGTX), CalciMedica (CALC)

TIPRANKS
·
May 15